Company: REVB
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034584
Chunk: 41

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 16
Chunk 41
---
 were 960,469 and 2,422 potential shares of common stock excluded from the calculation of diluted net loss per share as their effect is anti-dilutive, respectively (see Note 8). The basic and diluted weighted-average shares used to compute net loss per share in the audited consolidated statements of operations includes the shares issued from the reverse stock split fractional share round down.Comprehensive LossThe Company has no components of comprehensive loss other than net loss. Thus, comprehensive loss is the same as net loss for the periods presented.Segment ReportingOperating segments are defined as components of an entity about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources in assessing performance. The Company has one operating segment. The Company’s chief operating decision maker, which is the Chief Executive Officer, manages the Company’s operations for the purposes of allocating resources and evaluating financial performance (see Note 12 for further information).Recent Accounting PronouncementsIn November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance is effective for the Company beginning in the annual reporting period ended December 31, 2024 and interim periods beginning in fiscal year 2025. The Company adopted this standard as of December 31, 2024, which adoption only impacted the Company's segment reporting disclosures (see Note 13 for further information).

 F-12

3. Balance Sheet DetailsPrepaid Expenses and Other Current AssetsPrepaid expenses and other current assets consisted of the following: 

        December 31,2024

        December 31,2023

        Prepaid insurance costs
         
        $
        17,198

        $
        55,215

        Other prepaid expenses & current assets

        49,501

        29,476

        Total prepaid expenses & current assets
         
        $
        66,699

        $
        84,691

       Property and Equipment, NetProperty and equipment, net consisted of the following: 

        December 31,2024

        December 31,2023

        Lab equipment
         
        $
        151,134

        $
        131,963

        Total